Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An update on angiogenesis therapy.

J Davda1, V Labhasetwar

  • 1Department of Pharmaceutical Sciences, Nebraska Medical Center, Omaha 68198-6025, USA.

Critical Reviews in Eukaryotic Gene Expression
|November 6, 2001
PubMed
Summary

Targeted delivery of proangiogenic growth factors shows promise for treating ischemia. Optimal drug delivery systems are crucial for therapeutic success and minimizing side effects like unwanted angiogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Controlled release implant dosage forms for cardiac arrhythmias: Review and perspectives.

Drug delivery·2016
Same author

Nanoparticle-mediated catalase delivery protects human neurons from oxidative stress.

Cell death & disease·2013
Same author

Inhibition of tumor angiogenesis and growth by nanoparticle-mediated p53 gene therapy in mice.

Cancer gene therapy·2012
Same author

Evaluation of new rosin derivatives for pharmaceutical coating.

International journal of pharmaceutics·2004
Same author

Efficiency of Dispatch and Infiltrator cardiac infusion catheters in arterial localization of nanoparticles in a porcine coronary model of restenosis.

Journal of drug targeting·2003
Same author

Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid.

Journal of microencapsulation·2001

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Vascular Biology

Background:

  • Angiogenesis, the formation of new blood vessels, is a therapeutic target for ischemia-related conditions.
  • Proangiogenic growth factors demonstrate potential in preclinical models for promoting tissue repair.
  • Clinical translation of growth factor therapies is limited by suboptimal delivery methods.

Purpose of the Study:

  • To review the mechanism of action of growth factors in angiogenesis.
  • To summarize the current status of growth factors in preclinical and clinical studies.
  • To discuss the challenges and strategies for effective drug delivery of angiogenic agents.

Main Methods:

  • Literature review of studies on growth factor mechanisms.
  • Analysis of preclinical and clinical trial data for proangiogenic therapies.
  • Evaluation of various drug delivery systems for targeted angiogenesis.

Main Results:

  • Growth factors can stimulate therapeutic angiogenesis but require precise delivery.
  • Lack of targeted delivery leads to systemic toxicity and limited efficacy.
  • Investigational drug delivery systems aim for sustained, localized growth factor release.

Conclusions:

  • Optimized drug delivery is essential for harnessing the therapeutic potential of angiogenesis.
  • Targeted delivery systems can improve efficacy and reduce adverse effects of growth factor therapy.
  • Further research into novel delivery strategies is critical for clinical application.

Related Experiment Videos